Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
7.48M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4.14M
-
Shares change
-
+681K
-
Total reported value, excl. options
-
$23.7M
-
Value change
-
+$3.69M
-
Number of buys
-
12
-
Number of sells
-
-10
-
Price
-
$5.73
Significant Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q1 2025
34 filings reported holding KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share as of Q1 2025.
KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.14M shares
of 7.48M outstanding shares and own 55.34% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (1.2M shares), Cormorant Asset Management, LP (603K shares), SR One Capital Management, LP (599K shares), ADAR1 Capital Management, LLC (299K shares), PERCEPTIVE ADVISORS LLC (278K shares), Woodline Partners LP (259K shares), SILVERARC CAPITAL MANAGEMENT, LLC (246K shares), AIGH Capital Management LLC (196K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (171K shares), and VANGUARD GROUP INC (153K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.